Trial intelligence / Profile preview

Phase III MenAC Conjugate Vaccine in Chinese Infants and Young Children

CTR20160001Phase 3Completed

Sponsor
Olin Biological
Start
Sep 2016
Modality
Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of meningococcal A+C conjugate vaccine in meningococcal meningitis, sponsored by Olin Biological. Started Sep 2016; status: completed.

02

Drugs

meningococcal A+C conjugate vaccine
03

Conditions

meningococcal meningitis

Beyond the preview

Go deeper on CTR20160001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call